CC BY-NC-ND 4.0 · Avicenna J Med 2014; 04(02): 48-50
DOI: 10.4103/2231-0770.130347
CASE REPORT

A concurrent episode of two neoplasms in a toddler-age child

Muaz A Alrazzak
Department of Pediatrics, Roswell Park Cancer Institute, Buffalo, New York, United States
,
Jenny ZablahAlabi
Department of Pediatrics, Miami Children′s Hospital, Miami, Florida, United States
,
Baraa Alrazzak
Department of Pediatrics, Marshall University, Huntington, West Virginia, United States
,
Guillermo De Angulo
Department of Pediatrics, Miami Children′s Hospital, Miami, Florida, United States
› Author Affiliations

Abstract

Childhood neoplasms are relatively rare and represent only about 1- 2% of the total incidence of neoplasms in United States. Concurrent episode of childhood cancer is uncommon and usually related to a cancer genetic syndrome. Li Fraumeni Syndrome refers to an autosomal dominant condition that is manifested by the development of certain cancers in early childhood and an increased lifetime risk for developing multiple primary cancers including sarcoma, breast cancer, leukemia, bone cancer, and others. We report a case of a 21-month-old girl who was found to have orbital embryonal rhabdomyosarcoma and adrenocortical tumor concurrently.



Publication History

Article published online:
09 August 2021

© 2014. Syrian American Medical Society. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • References

  • 1 D′Orazio JA. Inherited cancer syndromes in children and young adults. J Pediatr Hematol Oncol 2010;32:195-228.
  • 2 Frebourg T, Abel A, Bonaiti-Pellie C, Brugières L, Berthet P, Bressac-de Paillerets B, et al. Li-Fraumeni syndrome: Update, new data and guidelines for clinical management. Bull Cancer 2001;88:581-7.
  • 3 Masciari S, Dewanwala A, Stoffel EM, Lauwers GY, Zheng H, Achatz MI, et al. Gastric cancer in individuals with Li-Fraumeni syndrome. Genet Med 2011;13:651-7.
  • 4 Tinat J, Bougeard G, Baert-Desurmont S, Vasseur S, Martin C, Bouvignies E, et al. 2009 Version of the chompret criteria for Li Fraumeni syndrome. J Clin Oncol 2009;27:e108-9.
  • 5 Pinto C, Veiga I, Pinheiro M, Peixoto A, Pinto A, Lopes JM, et al. TP53 germline mutations in Portugal and genetic modifiers of age at cancer onset. Fam Cancer 2009;8:383-90.
  • 6 Villani A, Tabori U, Schiffman J, Shlien A, Beyene J, Druker H, et al. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: A prospective observational study. Lancet Oncol 2011;12:559-67.
  • 7 Bernstein L, Gurney JG. Carcinomas and other malignant epithelial neoplasms. In: Ries LA, Smith MA, Gurney JG, et al. editors. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995. Bethesda, MD, National Cancer Institute, SEER Program, 1999. p. 139-47.
  • 8 Lefevre M, Gerard-Marchant R, Chaussain JL, et al. Adrenal cortical carcinoma in children: 42 patients treated from 1958 to 1980. In: Humphrey GB, Grindey GB, Dehner LP, et al. editors. Adrenal and Endocrine Tumors in Children. Boston, MA, Martinus Nijhoff, 1983. p. 265-76.
  • 9 Ries LA, Smith MA, Gurney JG, et al. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995. Bethesda, MD: National Cancer Institute; 1999. National Institutes of Health publication NIH 99-4649.
  • 10 Chong DY, Demirci H, Ronan SM, Flint A, Elner VM. Orbital Rhabdomyosarcoma in Li-Fraumeni Syndrome. Arch Ophthalmol 2007;125:566-9.
  • 11 Donaldson SS, Anderson JR. Rhabdomyosarcoma: Many similarities, a few philosophical differences. J Clin Oncol 2005;23:2586-7.
  • 12 Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998;392:402-5.